These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25203978)

  • 21. The Drug Quality and Security Act--mind the gaps.
    Outterson K
    N Engl J Med; 2014 Jan; 370(2):97-9. PubMed ID: 24369048
    [No Abstract]   [Full Text] [Related]  

  • 22. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
    Hinkley KN
    State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
    [No Abstract]   [Full Text] [Related]  

  • 23. HR 3204--The Drug Quality and Security Act: what does it say? What does it mean? What happens now?
    Int J Pharm Compd; 2013; 17(6):480-1. PubMed ID: 24579298
    [No Abstract]   [Full Text] [Related]  

  • 24. Regulation of compounding by the food and drug administration: a tale of 2 circuits.
    Williams KG
    J Pharm Pract; 2010 Oct; 23(5):502-6. PubMed ID: 21507854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compounding pharmacies: friend or foe.
    Springer R
    Plast Surg Nurs; 2013; 33(1):24-8. PubMed ID: 23446505
    [No Abstract]   [Full Text] [Related]  

  • 26. Sterile compounding: clinical, legal, and regulatory implications for patient safety.
    Qureshi N; Wesolowicz L; Stievater T; Lin AT
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1183-91. PubMed ID: 25443512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical compounding or pharmaceutical manufacturing? A regulatory perspective.
    Timko RJ; Crooker PE
    Int J Pharm Compd; 2014; 18(2):101-11. PubMed ID: 24881112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is in the can? The dilemma with dietary supplements.
    D'Aco K; Mooney R; Cusmano-Ozog K; Hofherr S; Lichter-Konecki U
    Mol Genet Metab; 2014 Dec; 113(4):239-40. PubMed ID: 25453401
    [No Abstract]   [Full Text] [Related]  

  • 29. U.S. Food and Drug Administration requests for input on HR 3204 enactment: the Drug Quality and Security Act of 2013.
    Miller DG
    Int J Pharm Compd; 2014; 18(1):35-6. PubMed ID: 24881338
    [No Abstract]   [Full Text] [Related]  

  • 30. Compliance policy guide addresses prescription drug compounding.
    Ann Pharmacother; 1992 Jun; 26(6):868. PubMed ID: 1611176
    [No Abstract]   [Full Text] [Related]  

  • 31. Final guidance for pharmacy compounding of human drug products under Section 503A.
    Blankenship CE
    Int J Pharm Compd; 2014; 18(5):379-80. PubMed ID: 25577886
    [No Abstract]   [Full Text] [Related]  

  • 32. International Academy of Compounding Pharmacists' recommendations for state-based legislative and regulatory initiatives.
    Miller DG
    Int J Pharm Compd; 2013; 17(1):48-9. PubMed ID: 23627246
    [No Abstract]   [Full Text] [Related]  

  • 33. Application of standards for compounding.
    Newton DW
    J Am Vet Med Assoc; 1994 Jul; 205(2):232-4. PubMed ID: 7928584
    [No Abstract]   [Full Text] [Related]  

  • 34. Application of the Food and Drug Administration's current good manufacturing practices regulations to pharmacy practice: a legal view.
    Fink JL
    Contemp Pharm Pract; 1979; 2(4):202-5. PubMed ID: 10244540
    [No Abstract]   [Full Text] [Related]  

  • 35. Contemporary pharmaceutical compounding.
    Allen LV
    Ann Pharmacother; 2003 Oct; 37(10):1526-8. PubMed ID: 14519042
    [No Abstract]   [Full Text] [Related]  

  • 36. Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):351. PubMed ID: 28333682
    [No Abstract]   [Full Text] [Related]  

  • 37. Applying Quality by Design Concepts to Pharmacy Compounding.
    Timko RJ
    Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "Negative" List.
    Allen LV
    Int J Pharm Compd; 2015; 19(4):311-3. PubMed ID: 26625568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compounding oversight a work in progress for states, FDA.
    Traynor K
    Am J Health Syst Pharm; 2016 Apr; 73(7):424-5. PubMed ID: 27001978
    [No Abstract]   [Full Text] [Related]  

  • 40. Taking the risk. Despite meningitis outbreak, some hospitals have little choice but to rely on compounding pharmacies.
    Lee J; Barr P
    Mod Healthc; 2012 Oct; 42(42):6-7, 16, 1. PubMed ID: 23163082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.